Neuropace Inc (NPCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 18,124 | 18,012 | 16,427 | 16,510 | 14,472 |
Cost of Goods | 4,781 | 4,467 | 4,194 | 4,538 | 4,100 |
Gross Profit | 13,343 | 13,545 | 12,233 | 11,972 | 10,372 |
Operating Expenses | 21,669 | 19,063 | 18,377 | 20,364 | 18,791 |
Operating Income | -7,545 | -5,051 | -5,950 | -7,854 | -8,319 |
Interest Expense | 2,258 | 2,236 | 2,191 | 2,125 | 1,965 |
Other Income | 878 | 1,087 | 884 | 855 | -91 |
Pre-tax Income | -8,925 | -6,200 | -7,257 | -9,124 | -10,375 |
Net Income Continuous | -8,925 | -6,200 | -7,257 | -9,124 | -10,375 |
Net Income | $-8,925 | $-6,200 | $-7,257 | $-9,124 | $-10,375 |
EPS Basic Total Ops | -0.32 | -0.22 | -0.28 | -0.36 | -0.41 |
EPS Basic Continuous Ops | -0.32 | -0.22 | -0.28 | -0.36 | -0.41 |
EPS Diluted Total Ops | -0.32 | -0.22 | -0.28 | -0.36 | -0.41 |
EPS Diluted Continuous Ops | -0.32 | -0.22 | -0.28 | -0.36 | -0.41 |
EPS Diluted Before Non-Recurring Items | -0.32 | -0.23 | -0.28 | -0.36 | -0.41 |
EBITDA(a) | $-7,422 | $-4,935 | $-5,840 | $-7,737 | $-8,207 |